scholarly journals In-Situ Forming Polymeric Drug Delivery Systems for Ophthalmic Use: An Overview

2021 ◽  
Vol 11 (3-S) ◽  
pp. 98-103
Author(s):  
Pranal Chhetri ◽  
Prithviraj Chakraborty ◽  
Debasmita Das ◽  
Tamanna Afnan

Delivery of drug into the ocular region is hindered by the protective layers that encapsulate the eyes, it has always been a major problem to get an effective bioavailability of the active drug in the ocular region due to the low precorneal resident time of most of the ocular delivery systems specifically convention once such as ointment, solution and suspension, as a result, most of the delivery systems are not capable of effectively treating ocular diseases. Several works have and are being carried out to overcome this problem one of which is using in-situ forming polymeric systems. Ocular In-situ gelling systems are a novel class of ocular drug delivery systems that are initially in a solution form but instantaneously gets converted into a viscous gel upon introduction or installation in the ocular cavity from which the active drugs get released in a sustained manner. This sol-to-gel phase transition depends upon various factors like change in pH, ion presence and change in temperature. Gel formed after the transformation has preferred viscosity along with bio-adhesive property, which increases the gel’s resident time in the ocular area and also releases the drug in a prolonged and sustained manner unlike conventional eye drops and ointments. This review emphasizes various ocular in-situ systems namely, pH triggered, Ion activated, and Temperature triggered systems which have prolonged residence time in the cul-de-sac area of the eye, hence increasing the ocular bioavailability. Keywords: In-situ gel, Ocular Drug delivery, Ocular Bioavailability, Polymer

2007 ◽  
Vol 83A (3) ◽  
pp. 656-666 ◽  
Author(s):  
H. Ueda ◽  
M.C. Hacker ◽  
A. Haesslein ◽  
S. Jo ◽  
D.M. Ammon ◽  
...  

INDIAN DRUGS ◽  
2013 ◽  
Vol 50 (04) ◽  
pp. 5-25
Author(s):  
N.G.N Swamy ◽  
Z Abbas ◽  

Numerous attempts have been made to improve the bioavailability from ocular drug delivery systems and to prolong the residence time of drugs applied topically onto the eye. Conventional ocular drug delivery systems such as eye drops and ointments are inefficient, whereas, systemic administration requires high doses which may result in significant toxicity. Therefore, a need arises to develop novel drug delivery carrier systems capable of increasing ocular bioavailability and decreasing both local and systemic cytotoxicity. Nanotechnology is expected to revolutionize ocular drug delivery. Solid lipid nanoparticles (SLNs) introduced in 1991 represent an alternative carrier system to traditional colloidal carriers, such as emulsions, liposomes and polymeric micro- and nanoparticles. SLNs do not show biotoxicity as they are prepared from physiological lipids and are ideal ocular drug delivery systems as they can enhance the corneal absorption of drugs and improve the ocular bioavailability of both hydrophilic and lipophilic drugs. SLNs have another advantage of allowing autoclave sterilization, an indispensible step in the formulation of ocular preparations. In this review a special attention has been given to the nature of lipids and surfactants commonly used for SLNs production. This article also reviews in detail the various fabrication methods, characterization, sterilization, and stabilization techniques for SLNs. In-vitro and in-vivo methods to study the drug release profile from SLNs have also been mentioned. A summary of previous studies involving the use of SLNs in ocular drug delivery is provided, along with a critical evaluation of SLNs as a potential colloidal ocular drug delivery system.


Author(s):  
Marie Dubar ◽  
Martin Lizambard ◽  
Elisabeth Delcourt-Debruyne ◽  
Fareeha Batool ◽  
Olivier Huck ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document